| UniProt ID | PROS_HUMAN | |
|---|---|---|
| UniProt AC | P07225 | |
| Protein Name | Vitamin K-dependent protein S | |
| Gene Name | PROS1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 676 | |
| Subcellular Localization | Secreted. | |
| Protein Description | Anticoagulant plasma protein; it is a cofactor to activated protein C in the degradation of coagulation factors Va and VIIIa. It helps to prevent coagulation and stimulating fibrinolysis.. | |
| Protein Sequence | MRVLGGRCGALLACLLLVLPVSEANFLSKQQASQVLVRKRRANSLLEETKQGNLERECIEELCNKEEAREVFENDPETDYFYPKYLVCLRSFQTGLFTAARQSTNAYPDLRSCVNAIPDQCSPLPCNEDGYMSCKDGKASFTCTCKPGWQGEKCEFDINECKDPSNINGGCSQICDNTPGSYHCSCKNGFVMLSNKKDCKDVDECSLKPSICGTAVCKNIPGDFECECPEGYRYNLKSKSCEDIDECSENMCAQLCVNYPGGYTCYCDGKKGFKLAQDQKSCEVVSVCLPLNLDTKYELLYLAEQFAGVVLYLKFRLPEISRFSAEFDFRTYDSEGVILYAESIDHSAWLLIALRGGKIEVQLKNEHTSKITTGGDVINNGLWNMVSVEELEHSISIKIAKEAVMDINKPGPLFKPENGLLETKVYFAGFPRKVESELIKPINPRLDGCIRSWNLMKQGASGIKEIIQEKQNKHCLVTVEKGSYYPGSGIAQFHIDYNNVSSAEGWHVNVTLNIRPSTGTGVMLALVSGNNTVPFAVSLVDSTSEKSQDILLSVENTVIYRIQALSLCSDQQSHLEFRVNRNNLELSTPLKIETISHEDLQRQLAVLDKAMKAKVATYLGGLPDVPFSATPVNAFYNGCMEVNINGVQLDLDEAISKHNDIRAHSCPSVWKKTKNS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 47 | Gamma-carboxyglutamic_acid | RRANSLLEETKQGNL HHHHHHHHHHHCCCH | 69.76 | 2820795 | |
| 47 | 4-carboxyglutamate | RRANSLLEETKQGNL HHHHHHHHHHHCCCH | 69.76 | - | |
| 47 | Gamma-carboxyglutamic_acid | RRANSLLEETKQGNL HHHHHHHHHHHCCCH | 69.76 | 2820795 | |
| 48 | 4-carboxyglutamate | RANSLLEETKQGNLE HHHHHHHHHHCCCHH | 62.36 | - | |
| 48 | Gamma-carboxyglutamic_acid | RANSLLEETKQGNLE HHHHHHHHHHCCCHH | 62.36 | 2820795 | |
| 48 | Gamma-carboxyglutamic_acid | RANSLLEETKQGNLE HHHHHHHHHHCCCHH | 62.36 | 2820795 | |
| 55 | Gamma-carboxyglutamic_acid | ETKQGNLERECIEEL HHHCCCHHHHHHHHH | 50.89 | 2820795 | |
| 55 | Gamma-carboxyglutamic_acid | ETKQGNLERECIEEL HHHCCCHHHHHHHHH | 50.89 | 2820795 | |
| 55 | 4-carboxyglutamate | ETKQGNLERECIEEL HHHCCCHHHHHHHHH | 50.89 | - | |
| 57 | Gamma-carboxyglutamic_acid | KQGNLERECIEELCN HCCCHHHHHHHHHCC | 30.39 | 2820795 | |
| 57 | 4-carboxyglutamate | KQGNLERECIEELCN HCCCHHHHHHHHHCC | 30.39 | - | |
| 57 | Gamma-carboxyglutamic_acid | KQGNLERECIEELCN HCCCHHHHHHHHHCC | 30.39 | 2820795 | |
| 60 | 4-carboxyglutamate | NLERECIEELCNKEE CHHHHHHHHHCCHHH | 57.48 | - | |
| 60 | Gamma-carboxyglutamic_acid | NLERECIEELCNKEE CHHHHHHHHHCCHHH | 57.48 | 2820795 | |
| 60 | Gamma-carboxyglutamic_acid | NLERECIEELCNKEE CHHHHHHHHHCCHHH | 57.48 | 2820795 | |
| 61 | 4-carboxyglutamate | LERECIEELCNKEEA HHHHHHHHHCCHHHH | 38.42 | - | |
| 61 | Gamma-carboxyglutamic_acid | LERECIEELCNKEEA HHHHHHHHHCCHHHH | 38.42 | 2820795 | |
| 61 | Gamma-carboxyglutamic_acid | LERECIEELCNKEEA HHHHHHHHHCCHHHH | 38.42 | 2820795 | |
| 66 | 4-carboxyglutamate | IEELCNKEEAREVFE HHHHCCHHHHHHHHC | 42.78 | - | |
| 66 | Gamma-carboxyglutamic_acid | IEELCNKEEAREVFE HHHHCCHHHHHHHHC | 42.78 | 2820795 | |
| 66 | Gamma-carboxyglutamic_acid | IEELCNKEEAREVFE HHHHCCHHHHHHHHC | 42.78 | 2820795 | |
| 67 | Gamma-carboxyglutamic_acid | EELCNKEEAREVFEN HHHCCHHHHHHHHCC | 55.42 | 2820795 | |
| 67 | Gamma-carboxyglutamic_acid | EELCNKEEAREVFEN HHHCCHHHHHHHHCC | 55.42 | 2820795 | |
| 67 | 4-carboxyglutamate | EELCNKEEAREVFEN HHHCCHHHHHHHHCC | 55.42 | - | |
| 70 | Gamma-carboxyglutamic_acid | CNKEEAREVFENDPE CCHHHHHHHHCCCCC | 59.62 | 2820795 | |
| 70 | 4-carboxyglutamate | CNKEEAREVFENDPE CCHHHHHHHHCCCCC | 59.62 | - | |
| 70 | Gamma-carboxyglutamic_acid | CNKEEAREVFENDPE CCHHHHHHHHCCCCC | 59.62 | 2820795 | |
| 73 | Gamma-carboxyglutamic_acid | EEAREVFENDPETDY HHHHHHHCCCCCCCC | 66.94 | 2820795 | |
| 73 | Gamma-carboxyglutamic_acid | EEAREVFENDPETDY HHHHHHHCCCCCCCC | 66.94 | 2820795 | |
| 73 | 4-carboxyglutamate | EEAREVFENDPETDY HHHHHHHCCCCCCCC | 66.94 | - | |
| 77 | Gamma-carboxyglutamic_acid | EVFENDPETDYFYPK HHHCCCCCCCCCCHH | 58.12 | 2820795 | |
| 77 | 4-carboxyglutamate | EVFENDPETDYFYPK HHHCCCCCCCCCCHH | 58.12 | - | |
| 77 | Gamma-carboxyglutamic_acid | EVFENDPETDYFYPK HHHCCCCCCCCCCHH | 58.12 | 2820795 | |
| 78 | Phosphorylation | VFENDPETDYFYPKY HHCCCCCCCCCCHHH | 41.19 | - | |
| 91 | Phosphorylation | KYLVCLRSFQTGLFT HHHHHHHHHHCCHHH | 14.57 | 22210691 | |
| 98 | O-linked_Glycosylation | SFQTGLFTAARQSTN HHHCCHHHHHHHCCC | 25.17 | OGP | |
| 104 | Phosphorylation | FTAARQSTNAYPDLR HHHHHHCCCCCCCHH | 18.61 | - | |
| 104 | O-linked_Glycosylation | FTAARQSTNAYPDLR HHHHHHCCCCCCCHH | 18.61 | OGP | |
| 110 | Phosphorylation | STNAYPDLRSCVNAI CCCCCCCHHHHHHCC | 3.62 | - | |
| 122 | Phosphorylation | NAIPDQCSPLPCNED HCCCCCCCCCCCCCC | 24.68 | - | |
| 122 | O-linked_Glycosylation | NAIPDQCSPLPCNED HCCCCCCCCCCCCCC | 24.68 | OGP | |
| 136 | Hydroxylation | DGYMSCKDGKASFTC CCCEECCCCCEEEEE | 69.06 | - | |
| 259 | Phosphorylation | CAQLCVNYPGGYTCY HHHHHHCCCCCEEEE | 5.26 | - | |
| 266 | Phosphorylation | YPGGYTCYCDGKKGF CCCCEEEEECCCCCE | 5.93 | - | |
| 297 | Phosphorylation | PLNLDTKYELLYLAE ECCCCCHHHHHHHHH | 17.57 | 27461979 | |
| 301 | Phosphorylation | DTKYELLYLAEQFAG CCHHHHHHHHHHHHH | 19.25 | 27461979 | |
| 312 | Phosphorylation | QFAGVVLYLKFRLPE HHHHHHHEEEECCCC | 9.02 | 27461979 | |
| 331 | Phosphorylation | SAEFDFRTYDSEGVI EEEEECCEECCCCEE | 31.51 | 25072903 | |
| 332 | Phosphorylation | AEFDFRTYDSEGVIL EEEECCEECCCCEEE | 17.14 | 25072903 | |
| 334 | Phosphorylation | FDFRTYDSEGVILYA EECCEECCCCEEEEE | 26.32 | 25072903 | |
| 340 | Phosphorylation | DSEGVILYAESIDHS CCCCEEEEEEECCCH | 9.37 | 25072903 | |
| 343 | Phosphorylation | GVILYAESIDHSAWL CEEEEEEECCCHHHH | 25.74 | 25072903 | |
| 347 | Phosphorylation | YAESIDHSAWLLIAL EEEECCCHHHHHHHH | 19.86 | 25072903 | |
| 394 | Phosphorylation | SVEELEHSISIKIAK CHHHHCCCEEEEEHH | 14.51 | 24719451 | |
| 396 | Phosphorylation | EELEHSISIKIAKEA HHHCCCEEEEEHHHH | 22.35 | 24719451 | |
| 423 | Phosphorylation | PENGLLETKVYFAGF CCCCCEEEEEEECCC | 26.27 | 29083192 | |
| 499 | N-linked_Glycosylation | QFHIDYNNVSSAEGW EEEEECCCCCCCCCE | 28.90 | UniProtKB CARBOHYD | |
| 509 | N-linked_Glycosylation | SAEGWHVNVTLNIRP CCCCEEEEEEEEEEC | 14.25 | UniProtKB CARBOHYD | |
| 530 | N-linked_Glycosylation | MLALVSGNNTVPFAV EEEEEECCCCCCEEE | 33.23 | 16335952 | |
| 531 | N-linked_Glycosylation | LALVSGNNTVPFAVS EEEEECCCCCCEEEE | 46.08 | 2940598 | |
| 562 | N-linked_Glycosylation | ENTVIYRIQALSLCS ECCCHHHHHHHHHCC | 1.25 | 16335952 | |
| 594 | Phosphorylation | STPLKIETISHEDLQ CCCEEEEECCHHHHH | 31.11 | 28270605 | |
| 596 | Phosphorylation | PLKIETISHEDLQRQ CEEEEECCHHHHHHH | 28.39 | 28270605 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PROS_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PROS_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PROS_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FA5_HUMAN | F5 | physical | 10593904 | |
| RSSA_HUMAN | RPSA | physical | 21988832 | |
| TBK1_HUMAN | TBK1 | physical | 21988832 | |
| C4BPB_HUMAN | C4BPB | physical | 9628846 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 612336 | Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) | |||||
| 614514 | Thrombophilia due to protein S deficiency, autosomal recessive (THPH6) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-530, AND MASSSPECTROMETRY. | |